{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:51:24Z","timestamp":1769266284455,"version":"3.49.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.rdc.2013.02.006","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T08:15:45Z","timestamp":1363421745000},"page":"457-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Noninflammatory Myopathies"],"prefix":"10.1016","volume":"39","author":[{"given":"Alan N.","family":"Baer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Wortmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rdc.2013.02.006_bib1","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11926-996-0023-5","article-title":"Differential diagnosis of idiopathic inflammatory myopathies","volume":"8","author":"Baer","year":"2006","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.rdc.2013.02.006_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00131402-199912000-00002","article-title":"Incidence of irritable electromyography in inflammatory myopathy","volume":"1","author":"Lyu","year":"1999","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.rdc.2013.02.006_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ddrr.103","article-title":"The use of neuroimaging in the diagnosis of mitochondrial disease","volume":"16","author":"Friedman","year":"2010","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/j.rdc.2013.02.006_bib4","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2007.11.018","article-title":"The in-depth evaluation of suspected mitochondrial disease","volume":"94","author":"Mitochondrial Medicine Society's Committee on Diagnosis","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.rdc.2013.02.006_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1258\/0004563011900786","article-title":"The ischaemic lactate-ammonia test","volume":"38","author":"Livingstone","year":"2001","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.rdc.2013.02.006_bib6","series-title":"Myology","first-page":"665","article-title":"Functional evaluation of metabolic myopathies","author":"Haller","year":"2004"},{"key":"10.1016\/j.rdc.2013.02.006_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pmr.2011.11.011","article-title":"Exercise testing in metabolic myopathies","volume":"23","author":"Tarnopolsky","year":"2012","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"10.1016\/j.rdc.2013.02.006_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ana.10263","article-title":"A\u00a0nonischemic forearm exercise test for McArdle disease","volume":"52","author":"Kazemi-Esfarjani","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib9","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/mus.1103","article-title":"Muscle glycogenoses","volume":"24","author":"DiMauro","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.02.006_bib10","first-page":"35","article-title":"Muscle glycogenoses: an overview","volume":"26","author":"Di Mauro","year":"2007","journal-title":"Acta Myol"},{"key":"10.1016\/j.rdc.2013.02.006_bib11","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa031836","article-title":"The effect of oral sucrose on exercise tolerance in patients with McArdle's disease","volume":"349","author":"Vissing","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.02.006_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.coph.2010.02.006","article-title":"Metabolic myopathies: the challenge of new treatments","volume":"10","author":"Angelini","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.rdc.2013.02.006_bib13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/WCO.0b013e32830dd5a6","article-title":"Lipid storage myopathies","volume":"21","author":"Bruno","year":"2008","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1212\/01.wnl.0000194241.35115.7c","article-title":"Coenzyme Q10 deficiency and isolated myopathy","volume":"66","author":"Horvath","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.rdc.2013.02.006_bib15","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.nmd.2008.06.382","article-title":"Distal lipid storage myopathy due to PNPLA2 mutation","volume":"18","author":"Ohkuma","year":"2008","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.rdc.2013.02.006_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/ng1951","article-title":"The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy","volume":"39","author":"Fischer","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.rdc.2013.02.006_bib17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/CND.0b013e3181903126","article-title":"Metabolic myopathies: update 2009","volume":"10","author":"van Adel","year":"2009","journal-title":"J\u00a0Clin Neuromuscul Dis"},{"key":"10.1016\/j.rdc.2013.02.006_bib18","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1056\/NEJMra022567","article-title":"Mitochondrial respiratory-chain diseases","volume":"348","author":"DiMauro","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.02.006_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ana.21217","article-title":"Prevalence of mitochondrial DNA disease in adults","volume":"63","author":"Schaefer","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/1097-4598(200102)24:2<170::AID-MUS30>3.0.CO;2-0","article-title":"Mitochondrial dysfunction and neuromuscular disease","volume":"24","author":"Nardin","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.02.006_bib21","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jnnp.2008.158279","article-title":"Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases","volume":"80","author":"Rahman","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2013.02.006_bib22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1542\/peds.2007-0391","article-title":"Mitochondrial disease: a practical approach for primary care physicians","volume":"120","author":"Haas","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2013.02.006_bib23","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1161\/01.str.0000034125.94759.41","article-title":"ACC\/AHA\/NHLBI clinical advisory on the use and safety of statins","volume":"33","author":"Pasternak","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/j.rdc.2013.02.006_bib24","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A\u00a0novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.02.006_bib25","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.rdc.2013.02.006_bib26","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2013.02.006_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2013the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.rdc.2013.02.006_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1001\/jama.292.21.2585","article-title":"Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs","volume":"292","author":"Graham","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2013.02.006_bib29","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/jama.2012.68311","article-title":"A\u00a0pain in the tuches","volume":"308","author":"Grupp","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.rdc.2013.02.006_bib30","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archneur.62.11.1709","article-title":"Muscle coenzyme Q10 level in statin-related myopathy","volume":"62","author":"Lamperti","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib31","first-page":"85","article-title":"Mitochondrial alterations in muscle biopsies of patients on statin therapy","volume":"36","author":"Gambelli","year":"2004","journal-title":"J\u00a0Submicrosc Cytol Pathol"},{"key":"10.1016\/j.rdc.2013.02.006_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.02.006_bib33","doi-asserted-by":"crossref","first-page":"32C","DOI":"10.1016\/j.amjcard.2005.12.008","article-title":"Statin safety: an appraisal from the adverse event reporting system","volume":"97","author":"Davidson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.rdc.2013.02.006_bib34","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study","volume":"359","author":"The SEARCH Collaborative Group","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.rdc.2013.02.006_bib35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/mus.20291","article-title":"Molecular clues into the pathogenesis of statin-mediated muscle toxicity","volume":"31","author":"Baker","year":"2005","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.rdc.2013.02.006_bib36","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1517\/14740338.2011.540568","article-title":"Statin-induced myopathy: a review and update","volume":"10","author":"Abd","year":"2011","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.rdc.2013.02.006_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrrheum.2012.85","article-title":"Implications of glucocorticoid therapy in idiopathic inflammatory myopathies","volume":"8","author":"Hanaoka","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2013.02.006_bib38","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1592\/phco.24.17.1784.52334","article-title":"Colchicine myotoxicity: case reports and literature review","volume":"24","author":"Wilbur","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.rdc.2013.02.006_bib39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/ard.2004.023200","article-title":"Antimalarial myopathy: an underdiagnosed complication? prospective longitudinal study of 119 patients","volume":"65","author":"Casado","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"Pt 6","key":"10.1016\/j.rdc.2013.02.006_bib40","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1093\/brain\/123.6.1229","article-title":"Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Clinical and genetic features","volume":"123","author":"Argov","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.rdc.2013.02.006_bib41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2002-33047","article-title":"Misunderstandings, misperceptions, and mistakes in the management of the inflammatory myopathies","volume":"22","author":"Kissel","year":"2002","journal-title":"Semin Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S0165-5728(03)00255-8","article-title":"Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study","volume":"142","author":"Confalonieri","year":"2003","journal-title":"J\u00a0Neuroimmunol"},{"key":"10.1016\/j.rdc.2013.02.006_bib43","first-page":"334","article-title":"Myotonic dystrophy and proximal myotonic myopathy","volume":"246","author":"Ricker","year":"1999","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.rdc.2013.02.006_bib44","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/jnnp.2008.158261","article-title":"The myotonic dystrophies: diagnosis and management","volume":"81","author":"Turner","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.rdc.2013.02.006_bib45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1128\/CMR.00001-08","article-title":"Bacterial, fungal, parasitic, and viral myositis","volume":"21","author":"Crum-Cianflone","year":"2008","journal-title":"Clin Microbiol Rev"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X13000070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:12:42Z","timestamp":1760181162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X13000070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0889857X13000070"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Noninflammatory Myopathies","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2013.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}